Clinical Trials Browser

Phase 2 × Carcinoma, Neuroendocrine × IFL protocol × Clear all

NCT02820857 2025-09-03

BEVANEC

Phase 2 Completed

Carcinoma, Neuroendocrine

NCT03168607 2017-06-01

Study to Evaluate the Efficiency of FOLFIRI as Seconde-line Chemotherapy in Neuroendocrine Carcinoma

Phase 2 Unknown

Carcinoma, Neuroendocrine